Update shared on04 Oct 2025
Fair value Decreased 0.51%Analysts have modestly reduced their price target for ConvaTec Group, reflecting a decline from £3.05 to £3.04 per share as they factor in revised sector outlooks and modest adjustments to growth expectations.
Analyst Commentary
Recent analyst revisions provide a mixed view of ConvaTec Group's prospects, with both optimistic and cautious signals emerging from updated research.
Bullish Takeaways
- Bullish analysts see the recent share price weakness as a potential buying opportunity, supported by the belief that the selloff may have been excessive compared to company fundamentals.
- Some upward adjustments to price targets highlight continued confidence in the company’s growth potential and execution, even in the face of broader sector headwinds.
- Persistent Buy and Overweight ratings indicate confidence in ConvaTec’s longer-term trajectory, signaling that its operational performance could drive a rebound in valuation.
- Upgrades from sector-neutral stances suggest improving sentiment on profitability or market positioning, particularly at current trading levels.
Bearish Takeaways
- Bearish analysts have trimmed price targets at several institutions, reflecting caution regarding slowing growth dynamics and possibly heightened sector risks.
- The modest reduction in targets indicates tempered expectations for near-term earnings upgrades or acceleration in revenue growth.
- Sustained Neutral ratings from some researchers indicate uncertainty surrounding valuation support and the sustainability of recent performance trends.
- Downward revisions, even while retaining positive ratings, suggest that while long-term potential remains, short-term performance may face pressure from external or company-specific challenges.
What's in the News
- RBC Capital upgraded ConvaTec to Outperform from Sector Perform with a price target of 315 GBp. The firm cited the recent selloff as likely overdone and considered it a potential buying opportunity (Periodical).
- ConvaTec Group began a share repurchase program and is authorized to buy back up to 10% of its issued share capital, following shareholder approval at the Annual General Meeting (Key Development).
- CEO Karim Bitar is taking medical leave of absence. CFO Jonny Mason has been appointed as Interim CEO, and Fiona Ryder is stepping in as Interim CFO (Key Development).
- The company proposed an interim dividend of 1.877 cents per share for 2025, to be distributed in October (Key Development).
- Revenue guidance for 2025 has been reaffirmed, with organic growth targeted at 5.5% to 7.0%, and InnovaMatrix® revenue expected to be at least $75 million (Key Development).
Valuation Changes
- Fair value per share has declined modestly from £3.05 to £3.04.
- The discount rate has fallen slightly from 8.10% to 7.99%.
- Revenue growth expectations have edged down, moving from 5.79% to 5.75%.
- The net profit margin has increased marginally from 13.30% to 13.32%.
- The future P/E ratio has decreased very slightly, shifting from 28.41x to 28.40x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.